Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
And concern about continued access rises steadily with cost: Among people paying $500 to $1,000 per month, more than 1 in 3 say they are very concerned about losing access, compared with 15% of those whose medication is fully covered
Milstein JL, Ferris HA
Request care now
The 8mg dose produced 22.8% average weight loss at 48 weeks in the phase 2 trial, with 100% of participants losing at least 5% and 91% losing at least 10% of body weight
Novo Nordisk), have both demonstrated around 20% weight loss after 72 weeks in previous clinical trials (SURMOUNT-1
Now you're hearing about tirzepatide and wondering: what's the actual difference, and which one is right for you
US$ 28.76
US$ 24.26
US$ 23.51
US$ 22.35
US$ 20.02
US$ 27.59
US$ 22.99
US$ 21.52
US$ 22.66
